pd168393 has been researched along with Disease Exacerbation in 2 studies
PD 168393 : A member of the class of quinazolines carrying bromoanilino and acrylamido substituents at positions 4 and 6 respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsieh, TF | 1 |
| Chen, CC | 1 |
| Ma, WL | 1 |
| Chuang, WM | 1 |
| Hung, XF | 1 |
| Tsai, YR | 1 |
| Lin, MH | 1 |
| Zhang, Q | 1 |
| Zhang, C | 1 |
| Chang, C | 1 |
| Shyr, CR | 1 |
| He, X | 1 |
| Zhang, H | 2 |
| Xiao, M | 1 |
| Kong, Y | 1 |
| Li, W | 1 |
2 other studies available for pd168393 and Disease Exacerbation
| Article | Year |
|---|---|
Epidermal growth factor enhances androgen receptor‑mediated bladder cancer progression and invasion via potentiation of AR transactivation.
Topics: Androgens; Animals; Butylhydroxybutylnitrosamine; Carcinogenesis; Castration; Disease Models, Animal | 2013 |
Inhibition of progression of PanIN through antagonizing EGFR.
Topics: Animals; Antineoplastic Agents; Carcinoma in Situ; Disease Progression; Drug Screening Assays, Antit | 2015 |